RNA aptamers targeting cancer stem cell marker CD133

被引：135

作者：

Shigdar, Sarah ^{[1
]}

Qiao, Liang ^{[2
,3
]}

Zhou, Shu-Feng ^{[4
]}

Xiang, Dongxi ^{[1
]}

Wang, Tao ^{[1
,5
]}

Li, Yong ^{[6
,7
]}

Lim, Lee Yong ^{[8
]}

Kong, Lingxue ^{[9
]}

Li, Lianhong ^{[10
]}

Duan, Wei ^{[1
,10
]}

机构：

[1] Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia

[2] Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Dept Med, Westmead, NSW 2145, Australia

[3] Univ Sydney, Western Clin Sch, Westmead, NSW 2145, Australia

[4] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33612 USA

[5] Zhengzhou Univ, Coll Nursing, Zhengzhou 450052, Peoples R China

[6] Univ New S Wales, Canc Care Ctr, St George Hosp, Kensington, NSW 2052, Australia

[7] Univ New S Wales, St George Clin Sch, Fac Med, Kensington, NSW 2052, Australia

[8] Univ Western Australia, Lab Drug Delivery, Crawley, WA 6009, Australia

[9] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3217, Australia

[10] Dalian Med Univ, Dept Pathol & Forens Sci, Dalian 116044, Peoples R China

来源：

CANCER LETTERS | 2013年 / 330卷 / 01期

关键词：

AC133; Cancer stem cell; CD133; RNA aptamer; SELEX; Therapeutic; CD133(+)CD44(+) POPULATION; IDENTIFICATION; EXPRESSION; AC133; THERAPY; PROTEIN; DIFFERENTIATION; IMMUNOTHERAPY; RECOGNITION; PROMININ-1;

D O I：

10.1016/j.canlet.2012.11.032

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The monoclonal antibody against the AC133 epitope of CD133 has been widely used as a cell surface marker of cancer stem cells in several different cancer types. Here, we describe the isolation and characterisation of two RNA aptamers, including the smallest described 15 nucleotide RNA aptamer, which specifically recognise the AC133 epitope and the CD133 protein with high sensitivity. As well, both these aptamers show superior tumour penetration and retention when compared to the AC133 antibody in a 3D tumour sphere model. These novel CD133 aptamers will aid future development of cancer stem cell targeted therapeutics and molecular imaging. Crown Copyright (C) 2012 Published by Elsevier Ireland Ltd. All rights reserved.

引用

页码：84 / 95

页数：12

共 50 条

[1] Interconnection of CD133 Stem Cell Marker with Autophagy and Apoptosis in Colorectal Cancer
Sipos, Ferenc
Muzes, Gyoergyi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
[2] Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma
Attia, S.
Atwan, N.
Arafa, M.
Shahin, R. A.
PATHOLOGICA, 2019, 111 (01) : 18 - 23
[3] Clinical significance of stem cell marker CD133 expression in colorectal cancer
Wang, Bin-Bin
Li, Zhi-juan
Zhang, Feng-Feng
Hou, Hai-Tao
Yu, Jing-Kui
Li, Feng
HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (03) : 299 - 306
[4] CD133 in Breast Cancer Cells: More than a Stem Cell Marker
Brugnoli, Federica
Grassilli, Silvia
Al-Qassab, Yasamin
Capitani, Silvano
Bertagnolo, Valeria
JOURNAL OF ONCOLOGY, 2019, 2019
[5] How powerful is CD133 as a cancer stem cell marker in brain tumors?
Cheng, Jin-Xiang
Liu, Bo-Lin
Zhang, Xiang
CANCER TREATMENT REVIEWS, 2009, 35 (05) : 403 - 408
[6] Prognostic significance of cancer stem cell marker CD133 expression in breast cancer
Han, Linjun
Gao, Xianshu
Gu, Xiaobin
Guo, Wei
Ma, Mingwei
Qi, Xin
Cui, Ming
Xie, Mu
Bai, Yun
Peng, Chuan
Li, Xiaoying
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03): : 4829 - 4837
[7] Expression of the stem cell marker CD133 in malignant meningioma
Maier, Andrea D.
Mirian, Christian
Bartek, Jiri, Jr.
Juhler, Marianne
Bartkova, Jirina
Broholm, Helle
Mathiesen, Tiit, I
CLINICAL NEUROPATHOLOGY, 2021, 40 (03) : 151 - 159
[8] CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Yaojiong
Wu, Philip Yuguang
STEM CELLS AND DEVELOPMENT, 2009, 18 (08) : 1127 - 1134
[9] CD133 is not an accurate marker for colon cancer stem cells
Sticca, Robert
Murphy, Tonya
Goosens, James
CANCER RESEARCH, 2009, 69
[10] Is CD133 a marker Of metastatic colon cancer stem cells?
LaBarge, Mark A.
Bissell, Mina J.
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06): : 2021 - 2024

← 1 2 3 4 5 →